Anbio Biotechnology Deferred Costs, Noncurrent
Anbio Biotechnology (NNNN) had Deferred Costs, Noncurrent of $0 as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2026-04-07
- 2025-12-31: Deferred Costs, Noncurrent $0.00.
- 2024-12-31: Deferred Costs, Noncurrent $387.44K.
- 2023-12-31: Deferred Costs, Noncurrent $42.84K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-04-07 |
| 2024-12-31 | $387.44K 20-F · filed 2026-04-07 |
| 2023-12-31 | $42.84K 20-F · filed 2025-04-28 |